LGRPv2

Gene search

Sequence information

Select	Gene	Cds	Cds_length	GC_content	Pep	Pep_length
	Vra6g0318	ATGGGAAAACGTGGTGAGGAAGAAGAGTGTGTTGGTTTCAGCTACGATGTGTTCATTAGCTTTCTAGGTGAAGATACTGGGAACAATTTTGTAGGGCATCTCCGTAAAGAGTTGGGTAGGAAGGGAATGGTGACTTTGAATGACGAGAGTGATATGAGGACAGAGGAAGGTCTTTCACCTGCTGTGTGTGAGGCCATTGAAGAATCTAGGATTTTCATCGTTGTGTTTTCTGAGAACTATGCATCTTCCACATGGTGTCTGGATGAACTTGTTAAGATTATCGAACGCACCCACACGAACAGTAAGCAAGTTGTTTACCCAGTGTTCTACCATGTAGATCCCTCAGATATACGGAAAATGAGAAATAGTTTCGGAAAACACATGACGGCACACGAAAATGAGATTGGAAAAGAGTCGCAGAGAATGCAGGCTTGGAGGTCTGCTTTGTCTGAAGCAGTTAACTTGCCGGGGATGCATGTTACCACCGGGTATGAAAACAATTTTATTGAAAAAATTGTTAAGAAAGTTCGTAAAAGCATAGCTCCTAAGCCTTTGTCTACCGGTGAAAATCTTGTTGGACTGGAGCCCCACATAGAAGAGGTTATGTCACTTTTGGATATGAATAATGATAAAACTGTAAGGATGTTGGGCATATATGGGCTTGGTGGAATTGGAAAAACGGAACTTGCCAAAGCTTTGTATGACAAAATTGTGCAAAACTTTGATGCTGCAAGTTTTCTTGCCGGTGTTAGAGAAAAATCAAACACAATCAATGGCATGGAAGAACTGCAAAAGACACTTTTATCTGAGATGTTAGAGGAGTCGGAAACTATGTTGGGAAGTACCAATAAAGGAATTTATGAAATAAAACGAAAGCTTTGCCGAAAGAAAGTTCTTTTGGTTCTTGACGACGTTGACGATAAAGAGGAGTTAGAAAATTTGGCAGGAGGTTGTGATTGGTTTGGTGTAGGTAGTAGGATTATTATTACGACAAGGGAAAAAGATGTCCTAATTGCTCACCATGTTGGACATATTTATGAAATGAAGGAACTTGATGAACAACATTCTTTGGAGCTCTTTTGTTGGAATGCCTTCGGACAAGGGGAGAGAATGGAATATGTGAAAAAGATACTTAAGGAATTTTGTTCAACATCCAACATGAAAGTACTTGTCAATAAATCACTCATAACTATCGAGAATGACAGGCTGAAGATGCATGATCTAATACAAGATATGGGTAGACAGATTGTTAGGCAGGAAGCACCAGATAATCCTGGACAACGTAGCAGAATATTGGATTACGAAGATGTTATTGAAATACTAACGAAAGATTCGGGAAGTGATAAGATTCAAGGGATTAAGCTAGATCCTCCTAAGCAAGCAGAAGTAAAATGGAGTGGAACTGAGTTTGGGAAAATGAAATGGCTCAGAATTCTAATTGTTCGAAACACATCCTTTTCATCTGAACTTCAACATTTACCAAATCATTTAAGACTACTTCACTGGGACAACTATCCTTCAAAGTCTTTCCCCCAAAAATTCCATCCAAAGAAAATCGTTGTTTTCAATTTGCCTAGAAGTTCTCTAACATTCCAAGACCCATTCAAGAAATTTCCATGCTTGACTAATATGGACTTTTCATATAACCAACGTATCATCGAAATACCTGATGTGTCTGAACTTCAGAATCTAAGAGAACTGAGACTTGATCATTGTAGAAACCTAATTGCAGTCCATCAATCTGTTGGATTTTTGAAAAAGCTTTCTCATTTAAGTGTTTCAGAATGCACAAAACTTCAAAACTTCCTGTCCAGAATGTTTCTACCATCTTTAGAAGTTTTTGATCTTAATCTATGTGAAAGAGTTGGTCACTTCCCAGAGATAATGCAAGAAATGACAAAGCCATTGAAGATTTATATGATAAATACGGGTATTCAAGAGCTTCCGGAATCCATTAGTAAACTTATTGGGCTTGTTTTTATAGACATATCGAATAACAGGCAACTTAAATATCTGCCAAGCAGCTTATTCATGTTGCCAAATGTTGATTCCTTCAAAATCGAAGCATGTTCGAAACTTGGACAATCCTTCAGAAGTTTGGTTCAACACCCTTCAAAAGTCAATGTTCGTCCGAAATTACGATCACTGAATTTTCAAAAGGGTAACTTGTCTGATGAAGATCTTCTTGCGATTCTTTGCTACTTTCCGAAATTGGAAGAATTGATTGTTTCAGAGAACAATTTTGTATATATCCCTTCATGCATCAAGGAATGTGGTGACTTGACAAGTCTCGATTTGAATGGATGTAAGAAGCTTAAAAAAATTCCAGAACTCACTAGCTTGAGAATTCTTGATGTTCATCATTGTTTCTACCTTGAAGAAATCTCAGAGTTACCGTCTACTGTTGAGAAAGTAGATGCAAGATTTTGTTTCAAGTTAACAAAAGAGACATCAGACATGCTATGGTGTCAGGTGAAGAAAAGGGTTGCTGGAATAGAAATGGTGATGCCATTTATAACTGAGATTCCAGAATGGTTTAACTTTGTGGGGGTGGGAAGGATTCCTAGTTTCTGGATTCGTGGCAAGTTCCCTAACATTGTTCTAGCCATGATATTCCACTTCCAAAATGAGAGTGAAAGGAACAAATTCGTTCGCCGTCGCCTTGTTGATCTTCGTTTACTTATCAACGGTCGAAATGCTCCTGGCAAAGGGTACCGGGACTTCGAAATTGAAGCAGAACACATCTTGATATGTGATCTACGAGTTTTGTTCAGTGAGAAGGAGTGGTTTGGGCTTGATGCATTGGTGGAGAATGAGTGGAATCTGGTGCAGGTTGAGTATGAAGCCAGTTCGTCGTTGATGATAAGTGGTTGGGGAGCGTTTGTGTATGATGAAGGAAGCAACATGAAAGATGTCGCATTCACTTGTCCGAATCCCATGTATTCAGACAAGATGCCACAGACAATAATTCCTGAGAAAGATCCTATGGAGAAGTATAAAAAGAGGATACGGGAGCTACGTCTGGACGAAATATTTAAGAAGACGTTGACGGAATGGCAGGAGAACAAAGAAAGAGGAGGGGACAGGAGTCATGACAATTGCATCCGTATGGCATTGGGACAAATAAAGAAGATATCAGAGGATGCTGAGGATGCATTGAATTCAAAAGGGTCAGCTTTAGAAGATCCAAACTCCTACCTGAGGTGGCTGCTAGATACGTTAGAAAATGATGATGGAAAGCCTAAAGAGATTATCAAAGGTGATCTGGCGTTGGTAGTACAAAAGCATTCAGCGACAGGGAAGAAGAAGGAGGATAATGTAGGAGAAGCTTCATGCTCTAGGCATCACGGAAGAAAGGAGGAGGAAGAAGGGTACGATCCTGTGGTGGAAGCCCCAAGTATCCCTTTTTATACTTCAGTAGTCAGAGAACAAAGAGTAAACGATTCTGTAGAGGCAGATCTTCCGGAGGACATAGTGATGGAATTATTCTGTGAAGGAATGAAGGATGGACTTGTTGAGGCACAGAATGGATTTCCTTCTCTAGATATTGCTGAAACCAGTAACGCTGTGTTGGAGAAGGGTGATAAGGTTAGATGGGCACCTGATGTAGAAGAGCAAATATCGGTCGAAAGTAGGATATACATGACTGGAATTTACTCTGGACTCAAAGAAGCAAAGCTGAGGTTTCCTGATTTGGACATGTGGACAACAATAAATACTGTGGCAAAAAGGAAAGGGATCGAAGGAATTTTTGTATCAGCCTCTCAAGAAAAGCTGGGGTTCCCACATTTGGATTGGAGTACAGTGAAAGTTCCTCCTTCTGAGGACCCTCTGATGCAAATATTGATGAAGATGAAGCAACAAAGTAATTTTGAAGGCGAGGTGATGAGTAAACTGTTCTGGAAGTTGAAGGAGGAACACGAAGCTCTGCGCAACAAATTTGCAGAACTTGATGATGGAAATGAAAATGAATATGATGAGTGTGTTGAGAAGAGAGAAGAGAAGCATGATGGTGTGGGAAAATATGAAGAGATTAGTGGTGTTTTGAGAGGAAGAGGTGAAGAAATAGAGAGGCTGTACGATGCTGGGGTTGAAGGATTCAAGAGATCAGAAGAGTTTGAAGATGTGATGGGTGCAATATACTTGAATGGGCTTAGGGCAGGACTCCTTGAAGCACAGGCTCTCTTACTTAATCTCCTTACTCCACACAGAAACTGA	4218	0.3995	MGKRGEEEECVGFSYDVFISFLGEDTGNNFVGHLRKELGRKGMVTLNDESDMRTEEGLSPAVCEAIEESRIFIVVFSENYASSTWCLDELVKIIERTHTNSKQVVYPVFYHVDPSDIRKMRNSFGKHMTAHENEIGKESQRMQAWRSALSEAVNLPGMHVTTGYENNFIEKIVKKVRKSIAPKPLSTGENLVGLEPHIEEVMSLLDMNNDKTVRMLGIYGLGGIGKTELAKALYDKIVQNFDAASFLAGVREKSNTINGMEELQKTLLSEMLEESETMLGSTNKGIYEIKRKLCRKKVLLVLDDVDDKEELENLAGGCDWFGVGSRIIITTREKDVLIAHHVGHIYEMKELDEQHSLELFCWNAFGQGERMEYVKKILKEFCSTSNMKVLVNKSLITIENDRLKMHDLIQDMGRQIVRQEAPDNPGQRSRILDYEDVIEILTKDSGSDKIQGIKLDPPKQAEVKWSGTEFGKMKWLRILIVRNTSFSSELQHLPNHLRLLHWDNYPSKSFPQKFHPKKIVVFNLPRSSLTFQDPFKKFPCLTNMDFSYNQRIIEIPDVSELQNLRELRLDHCRNLIAVHQSVGFLKKLSHLSVSECTKLQNFLSRMFLPSLEVFDLNLCERVGHFPEIMQEMTKPLKIYMINTGIQELPESISKLIGLVFIDISNNRQLKYLPSSLFMLPNVDSFKIEACSKLGQSFRSLVQHPSKVNVRPKLRSLNFQKGNLSDEDLLAILCYFPKLEELIVSENNFVYIPSCIKECGDLTSLDLNGCKKLKKIPELTSLRILDVHHCFYLEEISELPSTVEKVDARFCFKLTKETSDMLWCQVKKRVAGIEMVMPFITEIPEWFNFVGVGRIPSFWIRGKFPNIVLAMIFHFQNESERNKFVRRRLVDLRLLINGRNAPGKGYRDFEIEAEHILICDLRVLFSEKEWFGLDALVENEWNLVQVEYEASSSLMISGWGAFVYDEGSNMKDVAFTCPNPMYSDKMPQTIIPEKDPMEKYKKRIRELRLDEIFKKTLTEWQENKERGGDRSHDNCIRMALGQIKKISEDAEDALNSKGSALEDPNSYLRWLLDTLENDDGKPKEIIKGDLALVVQKHSATGKKKEDNVGEASCSRHHGRKEEEEGYDPVVEAPSIPFYTSVVREQRVNDSVEADLPEDIVMELFCEGMKDGLVEAQNGFPSLDIAETSNAVLEKGDKVRWAPDVEEQISVESRIYMTGIYSGLKEAKLRFPDLDMWTTINTVAKRKGIEGIFVSASQEKLGFPHLDWSTVKVPPSEDPLMQILMKMKQQSNFEGEVMSKLFWKLKEEHEALRNKFAELDDGNENEYDECVEKREEKHDGVGKYEEISGVLRGRGEEIERLYDAGVEGFKRSEEFEDVMGAIYLNGLRAGLLEAQALLLNLLTPHRN*	1406

Annotation information

Select	Seq ID	Length	Analysis	Description	Start	End	IPR	GO
	Vra6g0318	1405	MobiDBLite	consensus disorder prediction	1097	1125	-	-
	Vra6g0318	1405	PRINTS	Disease resistance protein signature	215	230	-	-
	Vra6g0318	1405	PRINTS	Disease resistance protein signature	292	306	-	-
	Vra6g0318	1405	PRINTS	Disease resistance protein signature	559	575	-	-
	Vra6g0318	1405	SUPERFAMILY	Toll/Interleukin receptor TIR domain	9	157	IPR035897	-
	Vra6g0318	1405	ProSiteProfiles	TIR domain profile.	13	180	IPR000157	GO:0007165
	Vra6g0318	1405	Gene3D	-	12	176	IPR035897	-
	Vra6g0318	1405	Gene3D	-	177	345	IPR027417	-
	Vra6g0318	1405	SMART	till_3	14	155	IPR000157	GO:0007165
	Vra6g0318	1405	Pfam	TIR domain	15	179	IPR000157	GO:0007165
	Vra6g0318	1405	SUPERFAMILY	L domain-like	404	797	-	-
	Vra6g0318	1405	PANTHER	RESISTANCE PROTEIN (TIR-NBS-LRR CLASS), PUTATIVE-RELATED	21	366	-	-
	Vra6g0318	1405	PANTHER	RESISTANCE PROTEIN (TIR-NBS-LRR CLASS), PUTATIVE-RELATED	367	970	-	-
	Vra6g0318	1405	Gene3D	Ribonuclease Inhibitor	464	638	IPR032675	-
	Vra6g0318	1405	Gene3D	Ribonuclease Inhibitor	639	822	IPR032675	-
	Vra6g0318	1405	Pfam	NB-ARC domain	195	383	IPR002182	GO:0043531
	Vra6g0318	1405	PANTHER	LEUCINE-RICH REPEAT-CONTAINING PROTEIN	21	366	IPR044974	GO:0006952
	Vra6g0318	1405	PANTHER	LEUCINE-RICH REPEAT-CONTAINING PROTEIN	367	970	IPR044974	GO:0006952
	Vra6g0318	1405	SUPERFAMILY	P-loop containing nucleoside triphosphate hydrolases	184	390	IPR027417	-

Duplication type information

Select	Gene	Chromosome	Start	End	Duplicated_type
	Vra6g0318	Vra-Chr6	2372107	2377691	Dispersed/Tandem

Functional genes information

Select	Gene	Gene_start	Gene_end	Function	Ath_gene	Identity(%)	E-value	Score
	Vra6g0318	381	742	WRKY Transcription Factor Family	AT4G12020	34.204	1.83e-48	188

Pathway information

Select	Query	KO	Definition	Second KO	KEGG Genes ID	GHOSTX Score
	Vra6g0318	-		-	vun:114193909	1731.84